Tag:Biologics Price Competition and Innovation Act (BPCIA)

Professor Lietzan Speaks on Panel at Supreme Court IP Review

November 6th, 2017

Professor Erika Lietzan recently served as a panelist at the Supreme Court IP Review held at the Chicago-Kent College of Law. She discussed Sandoz, Inc. v. Amgen. Inc., a case…

Professor Lietzan Files Amicus Brief with U.S. Supreme Court in Patent Case

March 24th, 2017

Professor Lietzan recently filed an amicus brief in the United States Supreme Court, in a closely-watched case involving patent litigation under the Biologics Price Competition and Innovation Act (BPCIA). The…